NO20023749D0 - Kahalalid-forbindelser - Google Patents

Kahalalid-forbindelser

Info

Publication number
NO20023749D0
NO20023749D0 NO20023749A NO20023749A NO20023749D0 NO 20023749 D0 NO20023749 D0 NO 20023749D0 NO 20023749 A NO20023749 A NO 20023749A NO 20023749 A NO20023749 A NO 20023749A NO 20023749 D0 NO20023749 D0 NO 20023749D0
Authority
NO
Norway
Prior art keywords
kahalalide
kahalalide compounds
compounds
leads
preparing
Prior art date
Application number
NO20023749A
Other languages
English (en)
Other versions
NO331847B1 (no
NO20023749L (no
Inventor
Fernando Albericio
Ernest Giralt
Jose Carlos Jimenez
Angel Lopez
Ignacio Manzanares
Ignacio Rodrigues
Miriam Royo
Original Assignee
Pharma Mar Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharma Mar Sa filed Critical Pharma Mar Sa
Publication of NO20023749D0 publication Critical patent/NO20023749D0/no
Publication of NO20023749L publication Critical patent/NO20023749L/no
Publication of NO331847B1 publication Critical patent/NO331847B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K11/00—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Optical Record Carriers And Manufacture Thereof (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Silver Salt Photography Or Processing Solution Therefor (AREA)
  • Detergent Compositions (AREA)
NO20023749A 2000-02-09 2002-08-08 Kahalalid-forbindelse, farmasoytisk preparat som omfatter forbindelsen, anvendelse av forbindelsen for fremstilling av et medikament for behandling av kreft og fremgangsmate for syntetisering av en forbindelse. NO331847B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0002952.0A GB0002952D0 (en) 2000-02-09 2000-02-09 Process for producing kahalalide F compounds
PCT/GB2001/000576 WO2001058934A2 (en) 2000-02-09 2001-02-09 Kahalalide f and related compounds

Publications (3)

Publication Number Publication Date
NO20023749D0 true NO20023749D0 (no) 2002-08-08
NO20023749L NO20023749L (no) 2002-10-07
NO331847B1 NO331847B1 (no) 2012-04-23

Family

ID=9885232

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20023749A NO331847B1 (no) 2000-02-09 2002-08-08 Kahalalid-forbindelse, farmasoytisk preparat som omfatter forbindelsen, anvendelse av forbindelsen for fremstilling av et medikament for behandling av kreft og fremgangsmate for syntetisering av en forbindelse.

Country Status (28)

Country Link
US (2) US7482429B2 (no)
EP (3) EP1829889A3 (no)
JP (1) JP5188665B2 (no)
KR (1) KR100871489B1 (no)
CN (2) CN101597326B (no)
AT (1) ATE371667T1 (no)
AU (1) AU783542B2 (no)
BG (1) BG65926B1 (no)
BR (1) BR0108213A (no)
CA (1) CA2399187C (no)
CY (1) CY1106992T1 (no)
CZ (1) CZ304258B6 (no)
DE (1) DE60130192T2 (no)
DK (1) DK1254162T3 (no)
ES (1) ES2292558T3 (no)
GB (1) GB0002952D0 (no)
HK (1) HK1047290A1 (no)
HU (1) HUP0301817A3 (no)
IL (2) IL150981A0 (no)
MX (1) MXPA02007760A (no)
NO (1) NO331847B1 (no)
NZ (1) NZ520488A (no)
PL (1) PL207121B1 (no)
PT (1) PT1254162E (no)
RU (1) RU2280039C2 (no)
SK (1) SK11242002A3 (no)
UA (1) UA76949C2 (no)
WO (1) WO2001058934A2 (no)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6274551B1 (en) * 1994-02-03 2001-08-14 Pharmamar, S.A. Cytotoxic and antiviral compound
GB0002952D0 (en) * 2000-02-09 2000-03-29 Pharma Mar Sa Process for producing kahalalide F compounds
KR100834138B1 (ko) 2000-10-31 2008-06-02 파르마 마르, 에스.에이. 카할라리드 에프
US20050054555A1 (en) * 2001-10-19 2005-03-10 Jose Jimeno Kahalalide compounds for use in cancer therapy
GB0304367D0 (en) * 2003-02-26 2003-04-02 Pharma Mar Sau Methods for treating psoriasis
US7507708B2 (en) 2003-02-26 2009-03-24 Pharma Mar, S.A.U. Antitumoral compounds
GB0321066D0 (en) 2003-09-09 2003-10-08 Pharma Mar Sau New antitumoral compounds
GB0408958D0 (en) * 2004-04-22 2004-05-26 Pharma Mar Sa Convergent synthesis for kahalalide compounds
CN100396696C (zh) * 2004-04-23 2008-06-25 中国科学院海洋研究所 一种海洋绿藻在提取抗肿瘤活性环肽组分中的应用
US20100226919A1 (en) * 2007-10-19 2010-09-09 Pharma Mar, S.A. Antitumoral Treatments
US20100323021A1 (en) * 2008-01-30 2010-12-23 Pharma Mar, S.A. Antitumoral treatments
US20110015135A1 (en) * 2008-03-07 2011-01-20 Pharma Mar S.A. Antitumoral Treatments
CN103641891B (zh) * 2013-05-23 2017-03-22 深圳翰宇药业股份有限公司 一种制备Kahalalide F的方法
WO2017050259A1 (en) * 2015-09-23 2017-03-30 Xw Laboratories Inc. Prodrugs of gamma-hydroxybutyric acid, compositions and uses thereof
CN110709386B (zh) 2017-03-30 2022-06-07 凯瑞康宁生物工程（武汉）有限公司 双环杂芳基衍生物及其制备与用途
JOP20190254A1 (ar) 2017-04-27 2019-10-27 Pharma Mar Sa مركبات مضادة للأورام
CN114042070A (zh) 2018-09-30 2022-02-15 凯瑞康宁生物工程（武汉）有限公司 作为神经元组胺受体-3拮抗剂的化合物及其用途
AU2020405133B2 (en) 2019-12-20 2023-04-27 XWPharma Ltd. Methods of synthesizing 4-valyloxybutyric acid
CA3183185A1 (en) 2020-06-18 2021-12-23 Jia-Ning Xiang Pharmaceutical granulations of water-soluble active pharmaceutical ingredients
WO2021257886A1 (en) 2020-06-18 2021-12-23 XWPharma Ltd. Controlled release granulations of water-soluble active pharmaceutical ingredients
CN116261451A (zh) 2020-07-24 2023-06-13 凯瑞康宁生物工程有限公司 γ-羟基丁酸衍生物的药物组合物和药物动力学
CA3194665A1 (en) 2020-10-05 2022-04-14 Jia-Ning Xiang Modified release compositions of a gamma-hydroxybutyric acid derivative
CN117098533A (zh) 2021-03-19 2023-11-21 凯瑞康宁公司 γ-羟基丁酸衍生物的组合释放型制剂的药物动力学
WO2023205233A1 (en) * 2022-04-21 2023-10-26 Zevra Therapeutics, Inc. Gamma-hydroxybutyrate delivering compounds and processes for making and using them

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US39496A (en) * 1863-08-11 Improvement in ratchet-drills
CU22545A1 (es) * 1994-11-18 1999-03-31 Centro Inmunologia Molecular Obtención de un anticuerpo quimérico y humanizado contra el receptor del factor de crecimiento epidérmico para uso diagnóstico y terapéutico
US4943533A (en) * 1984-03-01 1990-07-24 The Regents Of The University Of California Hybrid cell lines that produce monoclonal antibodies to epidermal growth factor receptor
JPS6178719A (ja) * 1984-09-25 1986-04-22 Tanabe Seiyaku Co Ltd 総合輸液剤
GR870129B (en) * 1987-01-27 1987-02-04 Giatzidis Ippokratis Stable bicarbonate - glycylglycine dialysate for hemodialysis and peritoneal dialysis
US5399363A (en) * 1991-01-25 1995-03-21 Eastman Kodak Company Surface modified anticancer nanoparticles
HU219537B (hu) * 1991-03-06 2001-05-28 Merck Patent Gmbh. Humanizált és kiméra monoklonális antitestek, azokat tartalmazó gyógyászati készítmények, az antitesteket kódoló szekvenciát tartalmazó expressziós vektorok, valamint eljárás az antitestek előállítására
US5849704A (en) * 1991-12-20 1998-12-15 Novo Nordisk A/S Pharmaceutical formulation
AU661533B2 (en) * 1992-01-20 1995-07-27 Astrazeneca Ab Quinazoline derivatives
GB9302046D0 (en) * 1993-02-03 1993-03-24 Pharma Mar Sa Antiumoral compound-v
US6274551B1 (en) * 1994-02-03 2001-08-14 Pharmamar, S.A. Cytotoxic and antiviral compound
US5932189A (en) * 1994-07-29 1999-08-03 Diatech, Inc. Cyclic peptide somatostatin analogs
US5705511A (en) * 1994-10-14 1998-01-06 Cephalon, Inc. Fused pyrrolocarbazoles
GB9508538D0 (en) * 1995-04-27 1995-06-14 Zeneca Ltd Quinazoline derivatives
US5747498A (en) * 1996-05-28 1998-05-05 Pfizer Inc. Alkynyl and azido-substituted 4-anilinoquinazolines
JP3927248B2 (ja) 1995-07-11 2007-06-06 第一製薬株式会社 Ｈｇｆ凍結乾燥製剤
AU3766897A (en) * 1996-07-13 1998-02-09 Glaxo Group Limited Fused heterocyclic compounds as protein tyrosine kinase inhibitors
US6235883B1 (en) * 1997-05-05 2001-05-22 Abgenix, Inc. Human monoclonal antibodies to epidermal growth factor receptor
WO1998050406A1 (en) * 1997-05-09 1998-11-12 The General Hospital Corporation Cell proliferation related genes
GB9800569D0 (en) * 1998-01-12 1998-03-11 Glaxo Group Ltd Heterocyclic compounds
GB9803448D0 (en) 1998-02-18 1998-04-15 Pharma Mar Sa Pharmaceutical formulation
US6200598B1 (en) * 1998-06-18 2001-03-13 Duke University Temperature-sensitive liposomal formulation
NZ512189A (en) * 1998-11-19 2003-10-31 Warner Lambert Co N-[4-(3-chloro-4-fluoro-phenylamino)-7-(3-morpholin-4- yl-propoxy)-quinazolin-6-yl]-acrylamide useful as an irreversible inhibitor of tyrosine kinases
US7311924B2 (en) * 1999-04-01 2007-12-25 Hana Biosciences, Inc. Compositions and methods for treating cancer
UA74803C2 (uk) * 1999-11-11 2006-02-15 Осі Фармасьютікалз, Інк. Стійкий поліморф гідрохлориду n-(3-етинілфеніл)-6,7-біс(2-метоксіетокси)-4-хіназолінаміну, спосіб його одержання (варіанти) та фармацевтичне застосування
GB0002952D0 (en) * 2000-02-09 2000-03-29 Pharma Mar Sa Process for producing kahalalide F compounds
CA2406743A1 (en) * 2000-04-28 2001-11-08 The Trustees Of The University Of Pennsylvania Recombinant aav vectors with aav5 capsids and aav5 vectors pseudotyped in heterologous capsids
US6440465B1 (en) * 2000-05-01 2002-08-27 Bioderm, Inc. Topical composition for the treatment of psoriasis and related skin disorders
KR100834138B1 (ko) 2000-10-31 2008-06-02 파르마 마르, 에스.에이. 카할라리드 에프
US20050054555A1 (en) 2001-10-19 2005-03-10 Jose Jimeno Kahalalide compounds for use in cancer therapy
GB0304367D0 (en) * 2003-02-26 2003-04-02 Pharma Mar Sau Methods for treating psoriasis
US7507708B2 (en) 2003-02-26 2009-03-24 Pharma Mar, S.A.U. Antitumoral compounds
GB0321066D0 (en) * 2003-09-09 2003-10-08 Pharma Mar Sau New antitumoral compounds
GB0408958D0 (en) * 2004-04-22 2004-05-26 Pharma Mar Sa Convergent synthesis for kahalalide compounds

Also Published As

Publication number Publication date
JP2003522198A (ja) 2003-07-22
CY1106992T1 (el) 2012-09-26
CN101597326B (zh) 2014-07-09
NO331847B1 (no) 2012-04-23
ATE371667T1 (de) 2007-09-15
DE60130192D1 (de) 2007-10-11
BG65926B1 (bg) 2010-05-31
AU3208601A (en) 2001-08-20
KR20020092951A (ko) 2002-12-12
PL207121B1 (pl) 2010-11-30
SK11242002A3 (sk) 2003-06-03
ES2292558T3 (es) 2008-03-16
EP1254162B1 (en) 2007-08-29
BR0108213A (pt) 2003-03-05
US20040214755A1 (en) 2004-10-28
PT1254162E (pt) 2007-12-03
US7482429B2 (en) 2009-01-27
MXPA02007760A (es) 2002-10-23
RU2002123877A (ru) 2004-01-10
WO2001058934A3 (en) 2002-03-21
EP2258715A1 (en) 2010-12-08
US20080318849A1 (en) 2008-12-25
IL150981A (en) 2013-05-30
RU2280039C2 (ru) 2006-07-20
GB0002952D0 (en) 2000-03-29
NZ520488A (en) 2005-03-24
CA2399187A1 (en) 2001-08-16
PL356800A1 (en) 2004-07-12
DK1254162T3 (da) 2008-01-02
AU783542B2 (en) 2005-11-10
CA2399187C (en) 2011-04-19
CN1422278A (zh) 2003-06-04
EP1829889A2 (en) 2007-09-05
IL150981A0 (en) 2003-02-12
HK1047290A1 (en) 2003-02-14
HUP0301817A2 (hu) 2003-09-29
CN101597326A (zh) 2009-12-09
EP1254162A2 (en) 2002-11-06
KR100871489B1 (ko) 2008-12-05
CZ304258B6 (cs) 2014-02-05
WO2001058934A2 (en) 2001-08-16
HUP0301817A3 (en) 2011-10-28
EP1829889A3 (en) 2007-09-26
DE60130192T2 (de) 2008-05-21
NO20023749L (no) 2002-10-07
UA76949C2 (en) 2006-10-16
BG107020A (bg) 2003-05-30
JP5188665B2 (ja) 2013-04-24
CZ20022740A3 (cs) 2003-01-15

Similar Documents

Publication Publication Date Title
NO20023749L (no) Kahalalid-forbindelser
ATE333849T1 (de) In-vitro herstellung von transplantierbarem knorpelgewebe
FI971746A (fi) Booriesteri- ja -happoyhdisteet sekä näiden synteesi ja käyttö
EP1158047A4 (en) MEDIA COMPRISING A BIOLOGICAL SUBSTANCE
DE69931403D1 (de) Biegsame medizinische Vorrichtung
DE69131589T2 (de) Ribosomen-inaktivierende Proteine, inaktive Vorläuferformen derselben, Verfahren zur Herstellung und eine Methode zur Nutzung
DE69620671D1 (de) Gewebekulturflasche
ID22219A (id) Proses dekomposisi hidroperoksida
DE69512233D1 (de) Eine fertigungsstrasse zur herstellung von absorbierenden wegwerfartikeln
DE69024862T2 (de) Modifiziertes, biologisch aktives Protein
BR9404776A (pt) Processo para a preparação de 2,2-difluorceteno silil acetais e processo para a preparação de ésteres de ácido alfa,alfa-diflúor-beta-sililóxi-1,3-dioxolano-4-propanóico
DE29820752U1 (de) Anordnung zur Erzeugung von Biogas
DE60005440D1 (de) Anordnung zur Herstellung von Matrixen von Proben
DE69107546D1 (de) Verfahren zur Herstellung von Insektiziden, Akariziden und Nematiziden-2-Aryl-5-(trifluormethyl)-Pyrrolen.
DE69724214D1 (de) Verbessertes Kultivationsverfahren
ES2095544T3 (es) Metodo para la preparacion de compuestos de 2-aril-5-trifluormetilpirrol.
KR940022660U (ko) 유기물 발효기용 탈취장치
DE69117438D1 (de) Verfahren zur Herstellung von insektiziden, nematiziden und akariziden, in 4-Stellung substituierten 5-(Trifluormethyl) pyrrol-3-nitril-Verbindungen
KR970048709U (ko) 양액 재배용 베드벤치
ID22910A (id) Metode untuk memproduksi fibrinogen
KR960003584U (ko) 분재 소재 배양분
SE9900693D0 (sv) Novel process
FI4516U1 (fi) Jatkettu biologinen kasvihuonepuhdistamo
DE29504532U1 (de) Desinfektionslösung zur Anwendung bei biologischen Abfällen
NO972516D0 (no) Biologisk reinseanlegg for CO2

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees